Lidocaine gelLidocaine sprayLidocaine drops Pain intensitySide effectsNasogastric tube (NG tube).
Conditions
Interventions
Intervention 1: Intervention group 1: Lidocaine gel (using 2.5 ml (equivalent to 50 mg of effective lidocaine) of the gel in the 2% lidocaine tube manufactured by Sina Daru Company, Tehran, each ml of
Sponsors
Gonabad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Informed consent Patients requiring NGT (No. 16) as determined by the treating physician Age 18–60 years Hemodynamically stable condition No clinical harm from a 3–5 minute delay in tube placement
Exclusion criteria
Exclusion criteria: Pregnancy Patient discharge or development of any condition rendering the intervention unfeasible Being on anticoagulant therapy Having a skull base fracture and facial trauma Esophageal trauma, especially in the context of consuming caustic substances Esophageal obstruction, such as a neoplasm or foreign body Having an allergy to lidocaine Pain in the throat, nose, and ears
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: In both the intervention and control groups, measurements will be taken during the intervention, immediately after, and at 5 and 10 minutes following the catheterization procedure. Method of measurement: Pain intensity will be measured using the Visual Analog Scale (VAS).;Nausea (side effect). Timepoint: Side effects will be recorded during the intervention and immediately after the intervention through observation, questioning of the patient and the nurse in charge. Method of measurement: Through observation, questions from the patient and the nurse in charge will be recorded.;Vomiting (side effect). Timepoint: Side effects will be recorded during the intervention and immediately after the intervention through observation, questioning of the patient and the nurse in charge. Method of measurement: Through observation, questions from the patient and the nurse in charge will be recorded.;Cough (side effect). Timepoint: Side effects will be recorded during the intervention and immediately after the intervention through observation, questioning of the patient and the nurse in charge. Method of measurement: Through observation, questions from the patient and the nurse in charge will be recorded.;Epistaxis(side effect). Timepoint: Side effects will be recorded during the intervention and immediately after the intervention through observation, questioning of the patient and the nurse in charge. Method of measurement: Through observation, questions from the patient and the nurse in charge will be recorded.;Pulmonary aspiration (side effects). Timepoint: Side effects will be recorded during the intervention and immediately after the intervention through observation, questioning of the patient and the nurse in charge. Method of measurement: Through observation, questions from the patient and the nurse in charge will be recorded. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTahereh Balochi Bidakhti
Gonabad University of Medical Sciences
Outcome results
None listed